AVXL has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
AVXL has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. Anavex Life Sciences's General and Admin. Expense for the three months ended in Jun. 2024 was $2.86 Mil. Its General and Admin. Expense for the trailing twelve months (TTM) ended in Jun. 2024 was $10.85 Mil.
The historical data trend for Anavex Life Sciences's General and Admin. Expense can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Anavex Life Sciences Annual Data | |||||||||||||||||||||
Trend | Sep14 | Sep15 | Sep16 | Sep17 | Sep18 | Sep19 | Sep20 | Sep21 | Sep22 | Sep23 | |||||||||||
General and Admin. Expense | Get a 7-Day Free Trial | 6.85 | 5.86 | 9.02 | 13.07 | 12.04 |
Anavex Life Sciences Quarterly Data | ||||||||||||||||||||
Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | |
General and Admin. Expense | Get a 7-Day Free Trial | 3.25 | 2.59 | 2.61 | 2.79 | 2.86 |
General and Admin. Expense is the aggregate total of general managing and administering expenses for the company.
General and Admin. Expense for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $10.85 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of Anavex Life Sciences's General and Admin. Expense provided by GuruFocus.com. Please click on the following links to see related term pages.
Donhauser Peter D.o. | director | REGINA-KIRCHMAIER STRASSE 4, KAUFBEUREN 2M 87600 |
Steffen Thomas | director | FALLMERAYER STR. 19, MUNICH 2M 80796 |
Christopher U Missling | director, officer: President, CEO, CFO, Treasurer, other: Secretary | 61 MOULTON ST, CAMBRIDGE MA 02138 |
Athanasios Skarpelos | 10 percent owner | 14,RUE KLEBERG, GENEVA V8 CH-1201 |
Jiong Ma | director | 445 PARK AVENUE, 9TH FLOOR, NEW YORK NY 10022 |
Elliot Favus | director | 51 W 52ND STREET, 7TH FLOOR, NEW YORK NY 10091 |
Sandra Boenisch | officer: PFO & Treasurer | 51 WEST 52ND STREET, 7TH FLOOR, NEW YORK NY 10019 |
Claus Vander Velden | director | PO BOX MUENSTEREIFELER ST., COLOGNE 2M 50937 |
Bernd Metzner | director | 51 W 52ND STREET, 7TH FLOOR, NEW YORK NY 10019 |
George F Tidmarsh | director, officer: Executive Director | |
John Robert Chisholm | director | 16308 36A AVENUE, SURREY A1 V3S 0X5 |
William Sean Lowry | director | 1172 BAY STREET, SUITE 300, ONTARIO Z4 M5S1L9 |
David L. Tousley | director | 14610 PAWNEE LANE, LEAWOOD KS 66224 |
Harvey Lalach | director, officer: President CEO CFO | 4837 CANYON RIDGE CRESENT, KELOWNA A1 V1W 4A1 |
Alison E. Ayers | director | 27 O'CONNOR CIRCLE, WEST ORANGE NJ 07052 |
From GuruFocus
By Marketwired • 11-26-2024
By GuruFocus News • 10-09-2024
By Marketwired • 08-06-2024
By Marketwired • 05-22-2024
By PRNewswire • 05-10-2024
By PRNewswire • 05-13-2024
By Marketwired • 05-13-2024
By Marketwired • 05-09-2024
By Marketwired • 05-14-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.